Items where Author is "Bhingarkar, Aboli"
Group by: Item Type | No Grouping Jump to: University of Pittsburgh ETD Number of items: 1. University of Pittsburgh ETDBhingarkar, Aboli (2022) Duvelisib is a novel NFAT inhibitor that attenuates adalimumab immunogenicity. Master's Thesis, University of Pittsburgh. (Unpublished) |
This site is hosted by the University Library System of the University of Pittsburgh as part of its D-Scribe Digital Publishing Program
The ULS Office of Scholarly Communication and Publishing fosters and supports new modes of publishing and information-sharing among researchers.
The University of Pittsburgh and D-Scholarship@Pitt support Open Access to research.
![[feed]](/images/feed-icon-32x32.png){kind=icon}